How much can business expect to profit from smoking cessation?

Preventive Medicine
M M Kristein

Abstract

The data reviewed in this article, drawn from well-known, published sources; offer an estimate of the annual costs of smoking to the average employer. These costs range from +336 to +601 in January 1980 dollars per average smoking employee. The analysis is largely based on aggregate epidemiological data and, in general, the emphasis is on the under-estimating of the costs to business. It reports "averages" true for large populations and, therefore, is not individually predictive. The cost centers dealt with are insurance, medical, and others such as absenteeism, productivity, involuntary smoking, and occupational health risk. Included is a discussion of employer-sponsored smoking cessation programs and the benefits therefrom.

References

Sep 3, 1977·Lancet·A B Atkinson, J L Townsend
Jan 1, 1979·Annals of the New York Academy of Sciences·E C HammondH Seidman
Apr 19, 1979·The New England Journal of Medicine·E L Wynder, D Hoffmann
Feb 4, 1977·Science·M M KristeinE L Wynder
Jun 1, 1977·Preventive Medicine·M M Kristein
Dec 1, 1979·American Journal of Public Health·T HarrupK Soghikian
Dec 1, 1979·Journal of Epidemiology and Community Health·J L Townsend, T W Meade
Mar 9, 1978·The New England Journal of Medicine·B R Luce, S O Schweitzer
Sep 1, 1978·Medical Care·A BerkS J Mushkin
Sep 21, 1978·The New England Journal of Medicine·W J BlotJ F Fraumeni
Aug 1, 1978·Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association·L A Bjurstrom, N G Alexiou
Sep 1, 1978·Preventive Medicine·M H Mushinski, S D Stellman
Jul 1, 1976·Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association·L I Boden
Dec 1, 1976·Environmental Research·E C HammondE A Lew
Nov 1, 1970·Archives of Environmental Health·D J Smith
Jul 1, 1967·Journal of Chronic Diseases·J TruettW Kannel
Oct 4, 1980·Lancet·M Jacobsen
Jun 1, 1982·American Journal of Public Health·S L GortmakerH Ruch-Ross
Apr 1, 1982·The American Psychologist·S Schachter
Oct 21, 1982·The New England Journal of Medicine·J D KarkL Rannon
Apr 1, 1982·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·P N Lee
Jan 15, 1981·International Journal of Cancer. Journal International Du Cancer·D TrichopoulosB MacMahon
Dec 1, 1981·American Journal of Public Health·M M Kristein
Mar 27, 1980·The New England Journal of Medicine·J R White, H F Froeb
Jun 1, 1980·American Journal of Public Health·P Kotin, L A Gaul
Jun 1, 1980·American Journal of Public Health·D Bennett, B S Levy
Mar 1, 1980·International Journal of Epidemiology·S Wall
Jul 10, 1982·Journal of Health Economics·E M Lewitt, D Coate

❮ Previous
Next ❯

Citations

Mar 1, 1986·Preventive Medicine·S N BlairC L Sterling
Jan 1, 1988·Social Science & Medicine·R J Wheeler
Jan 1, 1988·Social Science & Medicine·M A Spilman
Nov 6, 1985·Patient Education and Counseling·D S Lane, W Bennison
Aug 16, 2003·Progress in Cardiovascular Diseases·James Lightwood
Aug 29, 1985·The New England Journal of Medicine·J E Fielding
Sep 11, 2002·The Journal of Psychology·Paula C Morrow, Teresa Leedle
Dec 1, 1996·Drug and Alcohol Review·R RichmondP Holt
Dec 7, 2002·Occupational and Environmental Medicine·S M McGheeL M Ho
Mar 26, 2005·Tobacco Control·J L SindelarS H Busch
Jan 1, 1992·American Journal of Public Health·J RyanE J Orav
Mar 1, 1993·American Journal of Public Health·R W JefferyJ E Baxter
Oct 1, 1990·Journal of Psychoactive Drugs·K L Sees
Dec 1, 1989·American Journal of Community Psychology·L A JasonP Kimball
Jan 1, 2008·Social Science & Medicine·Anne LandmanStanton Glantz
Jan 1, 1988·Preventive Medicine·R H ShipleyD W McFadden
Oct 1, 1989·British Journal of Addiction·A Markandya, D W Pearce
Jun 1, 1989·Risk Analysis : an Official Publication of the Society for Risk Analysis·B D Ostro
Jul 15, 1992·The American Journal of Medicine·G R Lesmes
Sep 16, 2004·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Harold S JavitzLisa M Jack
Jan 1, 1989·International Quarterly of Community Health Education·E D GloverC Mansfield
May 16, 2008·Health Promotion Practice·Peter Mulligan
Nov 1, 1989·Preventive Medicine·M M MaheuN G Schneider
Apr 1, 2009·Industrial & Labor Relations Review·Irina B Grafova, Frank P Stafford
Nov 1, 1995·Health Education Quarterly·R C BrownsonM P Eriksen
Apr 6, 1999·Medical Care Research and Review : MCRR·E K Adams, T L Young
Jan 1, 1990·American Journal of Health Promotion : AJHP·R L BerteraJ M Telepchak
Dec 9, 1994·American Journal of Health Promotion : AJHP·B S FlynnR H Secker-Walker
Oct 1, 1987·American Journal of Health Promotion : AJHP·W H Hendrix, G S Taylor
Aug 15, 2001·American Journal of Health Promotion : AJHP·W Max
Jan 1, 1987·American Journal of Health Promotion : AJHP·D C Iverson
Oct 6, 1991·American Journal of Health Promotion : AJHP·W D LynchD S Main
Oct 2, 2009·Circulation·Mercedes CarnethonUNKNOWN Council on Nutrition, Physical Activity and Metabolism
Apr 12, 2007·Journal of Occupational and Environmental Medicine·Kenneth C JacksonDiana Brixner
Jun 17, 2009·Expert Review of Pharmacoeconomics & Outcomes Research·Joseph MenzinJeno Marton
Sep 4, 1986·The New England Journal of Medicine·M J MartinR Rosner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.